Rodolff Nunes da Silva

The health facility as a risk factor for multidrug-resistant gram-negative bacteria in critically ill patients with COVID-19

A. Levin, E. Viecelli, M.N. Mateus, 2022, Clinics.

Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database.

M. Olandoski, S. Danese, A. Spinelli, 2014, Journal of Crohn's & colitis.

Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study

S. Danese, A. Spinelli, M. Sacchi, 2016, United European gastroenterology journal.

Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational Study

M. Olandoski, A. Spinelli, M. Sacchi, 2015, Intestinal research.